AGIO EBITDA Growth
Agios Pharmaceuticals Inc · EBITDA Growth
AGIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-159.58%period ending
AGIO TTM EBITDA YoY % (-71.64% → -159.58%)
Year-over-year change
High-resolution chart · PNG
AGIO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -159.5787% | |
| -158.4451% | |
| -156.4687% | |
| -155.2249% | |
| 294.8875% | |
| 306.6205% | |
| 309.4632% | |
| 444.8534% | |
| -77.1323% | |
| -64.8378% | |
| -54.7526% | |
| 40.6111% | |
| 43.7455% | |
| 40.1358% | |
| 35.6996% | |
| -5.3558% | |
| -4.5367% | |
| -0.2287% | |
| -15.8577% | |
| -7.9778% | |
| -3.8439% | |
| 0.9608% | |
| 27.1557% | |
| 21.697% | |
| 16.0125% | |
| 1.3459% | |
| -15.7785% | |
| -15.0313% | |
| -19.9608% | |
| -5.0719% | |
| -13.0248% | |
| -24.0666% | |
| -23.7112% | |
| -43.1269% | |
| -60.9826% | |
| -57.0025% | |
| -69.9135% | |
| -79.396% | |
| -69.2776% | |
| -75.8765% | |
| -165.6343% | |
| -191.1589% | |
| -118.6237% | |
| -166.222% | |
| -12.2552% | |
| -6.8879% | |
| -40.9235% | |
| -20.7725% | |
| -103.5678% | |
| -81.6009% | |
| -71.6388% |